Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
CTS
vs
S
S&P/ASX 300
Over the past 12 months, CTS has significantly outperformed S&P/ASX 300, delivering a return of +60% compared to S&P/ASX 300's 1% drop.
Stocks Performance
CTS vs S&P/ASX 300
Performance Gap
CTS vs S&P/ASX 300
Performance By Year
CTS vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Ceretas Ltd
Glance View
Ceretas Ltd is a AU-based company operating in Health Care Equipment & Supplies industry. Ceretas Limited is an Australia-based medical technology company. The firm is engaged in developing a portable, non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions (Ceretas Device). The firm's initial clinical focus is neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits involved in memory, cognition and mood. The Ceretas Device is a therapeutic ultrasound platform that delivers low-intensity focused ultrasound non-invasively through the skull to targeted regions of the brain. The system integrates three core components: a focused ultrasound transducer and signal chain that generates and delivers the acoustic energy; a fluid coupling system that ensures efficient transmission of ultrasound from the transducer to the scalp, and an image-guided neuronavigational system which directs the transducer to precise brain targets based on each patient’s individual MRI scan.